Managers / Q3 2019 · view latest →
Main Management ETF Advisors, LLC
CIK 0001698607 · 601 CALIFORNIA STREET, SUITE 300, SAN FRANCISCO, CA, 94108 · 415-217-5800
Summary
Main Management Etf Advisors, LLC reported $460M in U.S.-listed holdings across 12 positions for Q3 2019.
The portfolio is heavily concentrated: XLK alone accounts for 23.3% of reported value.
Compared with Q2 2019, the fund opened 3 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 100.0% · $460M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GDXVanEck Vectors Gold Miners ETF | NEW | +896.0K | 896.0K | +$24M | $24M |
| VLUEiShares Edge MSCI USA Value Factor ETF | NEW | +245.0K | 245.0K | +$20M | $20M |
| XLEEnergy Select Sector SPDR Fund | NEW | +336.0K | 336.0K | +$20M | $20M |
| Xtrackers Harvest CSI 300 China A-Shares ETF | SOLD OUT | −1.15M | 0 | −$32M | $0 |
| SMHVanEck Vectors Semiconductor ETF | SOLD OUT | −156.5K | 0 | −$17M | $0 |
| IBBiShares Nasdaq Biotechnology ETF | TRIMMED | −84.3K | 115.5K | −$10M | $11M |
| XBISPDR S&P Biotech ETF | TRIMMED | −107.2K | 192.5K | −$12M | $15M |
| VDCVanguard Consumer Staples ETF | ADDED | +78.3K | 378.0K | +$15M | $59M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | XLKTechnology Select Sector SPDR Fundhistory → | COM | 23.27% | $107M | 1.33M |
| 2 | XLFFinancial Select Sector SPDR Fundhistory → | COM | 15.97% | $74M | 2.63M |
| 3 | VDCVanguard Consumer Staples ETFhistory → | COM | 12.86% | $59M | 378.0K |
| 4 | KBESPDR S&P Bank ETFhistory → | COM | 10.17% | $47M | 1.08M |
| 5 | ITBiShares U.S. Home Construction ETFhistory → | COM | 6.68% | $31M | 710.5K |
| 6 | XLVHealth Care Select Sector SPDR Fundhistory → | COM | 6.03% | $28M | 308.0K |
| 7 | IWSiShares Russell Mid-Cap Value ETFhistory → | COM | 5.46% | $25M | 280.0K |
| 8 | GDXVanEck Vectors Gold Miners ETFhistory → | COM | 5.20% | $24M | 896.0K |
| 9 | VLUEiShares Edge MSCI USA Value Factor ETFhistory → | COM | 4.37% | $20M | 245.0K |
| 10 | XLEEnergy Select Sector SPDR Fundhistory → | COM | 4.32% | $20M | 336.0K |
| 11 | XBISPDR S&P Biotech ETFhistory → | COM | 3.19% | $15M | 192.5K |
| 12 | IBBiShares Nasdaq Biotechnology ETFhistory → | COM | 2.50% | $11M | 115.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $2.7B | 116 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.8B | 124 | Feb 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $2.7B | 124 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $2.4B | 139 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $2.1B | 138 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $2.2B | 147 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $2.1B | 150 | Nov 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $2.0B | 40 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.9B | 42 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.7B | 42 | Feb 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.4B | 41 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.4B | 37 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.2B | 38 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.1B | 35 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $871M | 27 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $901M | 25 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.1B | 26 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.1B | 28 | Feb 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $990M | 27 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $960M | 27 | Nov 4, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2021 | $847M | 26 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $639M | 14 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $567M | 13 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $530M | 13 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $418M | 12 | May 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $516M | 12 | Feb 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $460M | 12 | Nov 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $434M | 11 | Aug 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $431M | 12 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.